Antipsychotics and Antidepressants in Veterinary Pharmacology

 
ANTIPSYCHOTICS
 
Dr. Kumari Anjana
Assistant Professor
Deptt. of Veterinary Pharmacology & Toxicology
Bihar Veterinary College, Bihar Animal Sciences University, Patna
 
ANTIPSYCHOTICS
 
These drugs are used in psychological disorders or
affective disorders.
Affective disorders are nervous disorders
characterized by 
abnormal mood.
The abnormal mood changes are:
       1) Depression and   2) Mania.
Therefore, these drugs are of two types:
       1) Antidepressants and 2) Antimaniac drugs
 
Antidepressants
 
Are drugs used in the treatment of 
abnormal mood and
behavior due to depression.
These drugs are also called as 
Thymoleptics or Mood
Elevators
.
Depression is characterized by 
feeling of sadness or
misery, loss of concentration or self-confidence,
disinterest in surroundings
, loss of libido, anorexia, 
lowered
energy and insomnia 
(sleeplessness) or hypersomnia
(excessive sleep).
Pharmacologically it is due to 
deficiency of monoamines in
limbic system in brain
.
Depression is treated by administering 
antidepressants
.
 
Classification of Antidepressants
 
Tricyclic Anti-depressants :
 
Impramine, 
  
Desipramine, 
   
Amitriptyline,
 
Protriptyline,    
 
Clomipramine, 
  
Doxepine,
 
Amoxapine, 
  
Mitrazapine, 
   
Nifazadone,
 
Trazodone, 
  
Maprotilne.
Monoamine Oxidase (MAO) Inhibitors-
 
Phenelzine, 
  
Tranylcypromine 
 
Isocarboxazid,
 
Moclobemide, 
 
Iproniazid, 
   
Selegiline.
5-HT re-uptake Inhibitors-
 
Fluoxetine, 
  
Fluvoxamine, 
   
Paroxetine,
 
Sertraline, 
  
Citralopram, 
   
Reboxitine, 
 
Paroxetine.
 
Classification of Antidepressants:
Tricyclic Anti-depressants:
NA+5 HT reuptake inhibitors
- Impramine, Protriptyline,  Amitriptyline,
                                                      Doxepine,    Clomipramine, Mitrazapine,
                                                      Nifazadone, Trazodone, Maprotilne.
Predominantly NA reuptake inhibitors
- Desipramine, Nortriptyline,
                                                      Amoxapine,      Reboxetine.
Monoamine Oxidase (MAO
A
) Inhibitors
-
- Phenelzine, Tranylcypromine
      
       
   
   Isocarboxazid,  Moclobemide,
 
      
       
   
   Iproniazid, clorgyline
(MAO
B
) Inhibitors
    
- 
   
   Selegiline.
5-HT re-uptake Inhibitors
-
 
 
   Fluoxetine, Fluvoxamine, Paroxetine,
          
   Sertraline, Citralopram, Reboxitine,
          
   Paroxetine.
 
   
Mode of Action
 
Tricyclic Anti-depressants- 
Act by inhibiting uptake of
noradrenaline and/or 5-HT by monoaminergic nerve terminals,
thus acutely facilitating transmission.
 
Monoamine Oxidase (MAO) Inhibitors-
- Inhibit one or both
forms of brain MAO: Increase stores of noradrenaline,
dopamine and 5-HT in nerve terminals. Inhibition of both MAO
types correlates with antidepressant activity.
 
5-HT re uptake Inhibitors-
- Act by inhibiting uptake of 5–HT
by tryptaminergic nerve terminals, thus acutely facilitating 5-
HT transmission.
 
MAO
A
 enzyme is specific to 
epinephrine and
norepinephrine 
and 
MAO
B
 
is specific to 
dopamine and 5-
HT.
Cheese, wine and chocolate contain tyramine, which
degraded in liver by MAO
A
 before systemic absorption.
 Ingestion of these foods in patients under MAO
inhibitor antidepressant therapy results in server
hypertensive crisis 
(Tyramine is adsorbed and taken up
by the adrenergic nerves, converted to 
octopamine, 
a
false transmitter, 
which releases norepinephrine from
adrenergic nerve terminals).
 
Antimaniac Drugs
 
Mania
 
is characterized by excessive 
exuberance,
enthusiasm, over self-confidence,  easy irritability,
aggressive behavior 
or hyperactivity and improper
judgement. Pharmacologically it is due to dopaminergic
over activity in the limbic system in brain.
Drugs for treatment of mania are:
   1
) Lithium carbonate, 2) Carbamazepine and 3) Valproate.
 These drugs are also called as 
mood stabilizing drugs.
 
Lithium carbonate
 
Lithium is a small monovalent cation (Li
+
).
Lithium readily enters excitable cells through the
Na
+
 channels 
displacing intracellular K
+
 and is nearly
equally distributed inside and outside the cells (Na
+
and K
+
).
The influx of K
+
 is reduced by inhibition of Na
+
/K
+
ATPase and the electrical gradient of K
+
(increased
extracellular K
+
 level).
The reversal of K
+ 
levels results in lowered neuronal
excitability causing calming of the maniac individual.
 
Lithium carbonate      
contd…
 
It also reduces release of norepinephrine and
dopamine in brain, without affecting 5-HT release.
 Lithium is also believed interfere with the
transduction mechanisms of central adrenergic
receptor activation 
through decreasing the formation
of second messenger cAMP and IP
3
.
Thus, lithium is acting through decreasing neuronal
excitability and correcting the imbalance of turnover
and/or actions of monoamines in brain.
Slide Note
Embed
Share

Antipsychotics and antidepressants play crucial roles in treating psychological and affective disorders in veterinary medicine. Antidepressants are vital in managing abnormal mood and behavior linked to depression, while antipsychotics help address various nervous disorders. The classification of antidepressants includes tricyclic antidepressants, MAO inhibitors, and 5-HT reuptake inhibitors. Each type acts through different mechanisms to alleviate symptoms and restore neurotransmitter balance in the brain.

  • Veterinary Pharmacology
  • Antipsychotics
  • Antidepressants
  • Psychological Disorders
  • Affective Disorders

Uploaded on Sep 18, 2024 | 0 Views


Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

E N D

Presentation Transcript


  1. ANTIPSYCHOTICS Dr. Kumari Anjana Assistant Professor Deptt. of Veterinary Pharmacology & Toxicology Bihar Veterinary College, Bihar Animal Sciences University, Patna

  2. ANTIPSYCHOTICS These drugs are used in psychological disorders or affective disorders. Affective disorders characterized by abnormal mood. The abnormal mood changes are: 1) Depression and 2) Mania. Therefore, these drugs are of two types: 1) Antidepressants and 2) Antimaniac drugs are nervous disorders

  3. Antidepressants Are drugs used in the treatment of abnormal mood and behavior due to depression. These drugs are also called as Thymoleptics or Mood Elevators. Depression is characterized by feeling of sadness or misery, loss of concentration disinterest in surroundings, loss of libido, anorexia, lowered energy and insomnia (sleeplessness) or hypersomnia (excessive sleep). Pharmacologically it is due to deficiency of monoamines in limbic system in brain. Depression is treated by administering antidepressants. or self-confidence,

  4. Classification of Antidepressants Tricyclic Anti-depressants : Impramine, Protriptyline, Clomipramine, Amoxapine, Trazodone, Monoamine Oxidase (MAO) Inhibitors- Phenelzine, Tranylcypromine Moclobemide, Iproniazid, 5-HT re-uptake Inhibitors- Fluoxetine, Fluvoxamine, Sertraline, Citralopram, Desipramine, Amitriptyline, Doxepine, Nifazadone, Mitrazapine, Maprotilne. Isocarboxazid, Selegiline. Paroxetine, Reboxitine, Paroxetine.

  5. Classification of Antidepressants: Tricyclic Anti-depressants: NA+5 HT reuptake inhibitors- Impramine, Protriptyline, Amitriptyline, Doxepine, Clomipramine, Mitrazapine, Nifazadone, Trazodone, Maprotilne. Predominantly NA reuptake inhibitors- Desipramine, Nortriptyline, Amoxapine, Reboxetine. Monoamine Oxidase (MAOA) Inhibitors-- Phenelzine, Tranylcypromine Isocarboxazid, Moclobemide, Iproniazid, clorgyline (MAOB) Inhibitors - 5-HT re-uptake Inhibitors- Fluoxetine, Fluvoxamine, Paroxetine, Sertraline, Citralopram, Reboxitine, Paroxetine. Selegiline.

  6. Mode of Action Tricyclic Anti-depressants- Act by inhibiting uptake of noradrenaline and/or 5-HT by monoaminergic nerve terminals, thus acutely facilitating transmission. Monoamine Oxidase (MAO) Inhibitors-- Inhibit one or both forms of brain MAO: Increase stores of noradrenaline, dopamine and 5-HT in nerve terminals. Inhibition of both MAO types correlates with antidepressant activity. 5-HT re uptake Inhibitors-- Act by inhibiting uptake of 5 HT by tryptaminergic nerve terminals, thus acutely facilitating 5- HT transmission.

  7. MAOA norepinephrine and MAOB is specific to dopamine and 5- HT. Cheese, wine and chocolate contain tyramine, which degraded in liver by MAOA before systemic absorption. Ingestion of these foods in patients under MAO inhibitor antidepressant therapy results in server hypertensive crisis (Tyramine is adsorbed and taken up by the adrenergic nerves, converted to octopamine, a false transmitter, which releases norepinephrine from adrenergic nerve terminals). enzyme is specific to epinephrine and

  8. Antimaniac Drugs Mania is characterized by excessive exuberance, enthusiasm, over self-confidence, easy irritability, aggressive behavior or hyperactivity and improper judgement. Pharmacologically it is due to dopaminergic over activity in the limbic system in brain. Drugs for treatment of mania are: 1) Lithium carbonate, 2) Carbamazepine and 3) Valproate. These drugs are also called as mood stabilizing drugs.

  9. Lithium carbonate Lithium is a small monovalent cation (Li+). Lithium readily enters excitable cells through the Na+ channels displacing intracellular K+ and is nearly equally distributed inside and outside the cells (Na+ and K+). The influx of K+ is reduced by inhibition of Na+/K+ ATPase and the electrical gradient of K+(increased extracellular K+ level). The reversal of K+ levels results in lowered neuronal excitability causing calming of the maniac individual.

  10. Lithium carbonate contd It also reduces release of norepinephrine and dopamine in brain, without affecting 5-HT release. Lithium is also believed interfere with the transduction mechanisms of central adrenergic receptor activation through decreasing the formation of second messenger cAMP and IP3. Thus, lithium is acting through decreasing neuronal excitability and correcting the imbalance of turnover and/or actions of monoamines in brain.

  11. Thank You Thank You

Related


More Related Content

giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#